Evidence map›Paper›PMID 42109830›Full record

ArticleBiophysics reports2026

Leveraging pre-trained AI models for robust promoter sequence design in synthetic biology.

Gui Yang, Yijie Chen, Qinghua Guo, Xinyang Li, Zhen Zhou

Abstract read
In one paragraph

Article in Biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gui Yang *Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing 210023, China.
Yijie Chen *Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing 210023, China.
Qinghua Guo *Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing 210023, China.
Xinyang LiNanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing 210023, China.
Zhen ZhouNanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing 210023, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although artificial intelligence (AI) has begun to be applied in synthetic biology, it is limited by its reliance on large amounts of high-quality data, which presents a significant challenge in synthetic biology. Pre-trained models have profoundly influenced natural language processing by enabling systems to understand and generate human language with remarkable accuracy and efficiency by capturing complex linguistic patterns and contextual nuances. This study applies the concept of pre-trained models to promoter sequence analysis through an innovative pre-training and fine-tuning paradigm. Our analysis reveals that pre-trained DNA models, particularly DNABERT, consistently outperform non-pre-trained models in predicting promoter expression levels across various dataset sizes. Building on DNABERT's strengths, we developed the AI model Pymaker, which specializes in predicting yeast promoter expression levels. Additionally, we introduced a novel base mutation model to simulate promoter mutations, enabling the generation of new promoter sequences. By integrating Pymaker with this mutation model, we effectively screened for high-expression, mutation-resistant promoters. Experimental validation in Saccharomyces cerevisiae showed that these selected promoters significantly enhanced LTB protein expression. Notably, Pymaker's predictions demonstrated superior accuracy, achieving a three-fold increase in protein expression compared to traditional promoters. Our findings highlight the potential of Pymaker not only to identify robust promoters but also to significantly reduce reliance on conventional, labor-intensive experimental methods, heralding a new era in synthetic biology and genetic engineering with practical applications in biopharmaceuticals.

Indexed as

AIPre-train modelsPromotersSynthetic biology

Identifiers

PMID42109830
PMCPMC13153722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.